Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $122.93 USD
Change Today +0.78 / 0.64%
Volume 1.3M
As of 8:10 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David Altshuler M.D., Ph.D.

Chief Scientific Officer and Executive Vice President of Global Research, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 1 different industries.

See Board Relationships
49$785,378

Background*

Dr. David Altshuler, M.D., Ph.D. has been Chief Scientific Officer and Executive Vice President of Global Research at Vertex Pharmaceuticals Incorporated since January 2015. Dr. Altshuler is an Associate Professor of Genetics and of Medicine of Massachusetts General Hospital. Since 2012, Dr. Altshuler has been Adjunct Professor of Biology at MIT. He is an Associate Professor of Genetics and of Medicine at the Harvard Medical School, where Dr. Altshuler has served on ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2012-2014
Chief Scientific Officer and Executive Vice President of Global Research

Education*

BS
Massachusetts Institute of Technology
PhD
Harvard University
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options43,750
Unexercisable Options11,250
Total Number of Options55,000

Total Compensation*

Total Annual Cash Compensation$60,000
Total Calculated Compensation$785,378
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $122.93 USD +0.78

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.